Schering-Plough Reduced OTC Sales Forecast Due To GMP Problems

Certain OTC products manufactured by Schering-Plough will see reduced sales due to a problematic manufacturing process and control issues cited by FDA, the company said.

More from Archive

More from Pink Sheet